i) The drug-protein interaction network
ii) The table result of interaction with GINS4_Q9BRT9
| Protein | Type | Gene Name | Drug | Drug Source | R | FDR | Cancer | |
|---|---|---|---|---|---|---|---|---|
 |
GINS4_Q9BRT9 | Canonical | GINS4 | vinblastine | GDSC1:1004 | -0.157 | 2.051e-02 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | methotrexate | GDSC1:1008 | -0.202 | 1.997e-03 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | tretinoin | GDSC1:1009 | 0.144 | 3.543e-02 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | temsirolimus | GDSC1:1016 | -0.138 | 4.567e-02 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | AZD7762 | GDSC1:1022 | -0.155 | 2.200e-02 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | lestaurtinib | GDSC1:1024 | -0.145 | 3.451e-02 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | afatinib | GDSC1:1032 | 0.176 | 8.311e-03 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | NVP-BEZ235 | GDSC1:1057 | -0.188 | 4.469e-03 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | PD-0325901 | GDSC1:1060 | 0.173 | 9.472e-03 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | CYC-202 | GDSC1:110 | 0.205 | 1.717e-03 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | serdemetan | GDSC1:1133 | 0.174 | 9.253e-03 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | TW-37 | GDSC1:1149 | -0.241 | 1.689e-04 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | YK-4-279 | GDSC1:1239 | 0.15 | 2.781e-02 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | FK-866 | GDSC1:1248 | -0.171 | 1.050e-02 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | camptothecin | GDSC1:1494 | -0.171 | 1.054e-02 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | CP-466722 | GDSC1:152 | 0.14 | 4.154e-02 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | GDC-0941 | GDSC1:1527 | -0.174 | 9.271e-03 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | pevonedistat | GDSC1:1529 | -0.174 | 8.932e-03 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | SB-715992 | GDSC1:208 | -0.242 | 1.609e-04 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | TL-2-105 | GDSC1:211 | 0.146 | 3.308e-02 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | TAK-715 | GDSC1:221 | 0.222 | 6.115e-04 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | enzastaurin | GDSC1:229 | 0.138 | 4.464e-02 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | idelalisib | GDSC1:238 | 0.137 | 4.598e-02 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | WZ3105 | GDSC1:252 | -0.186 | 4.956e-03 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | NPK76-II-72-1 | GDSC1:257 | 0.139 | 4.321e-02 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | tubastatin-A | GDSC1:265 | 0.239 | 1.904e-04 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | AR-42 | GDSC1:272 | -0.18 | 6.806e-03 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | CUDC-101 | GDSC1:273 | -0.19 | 4.054e-03 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | belinostat | GDSC1:274 | -0.188 | 4.543e-03 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | CAY10603 | GDSC1:276 | -0.191 | 3.846e-03 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | GSK-2126458 | GDSC1:283 | -0.242 | 1.530e-04 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | PDK1 inhibitor 7 | GDSC1:287 | 0.165 | 1.423e-02 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | Bayer IKKb inhibitor | GDSC1:290 | 0.237 | 2.236e-04 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | masitinib | GDSC1:292 | 0.193 | 3.463e-03 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | amuvatinib | GDSC1:293 | 0.153 | 2.397e-02 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | MPS-1-IN-1 | GDSC1:294 | 0.139 | 4.363e-02 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | OSI-930 | GDSC1:298 | 0.155 | 2.236e-02 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | WY-090217 | GDSC1:3 | -0.156 | 2.077e-02 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | PI-103 | GDSC1:302 | -0.14 | 4.139e-02 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | WYE-125132 | GDSC1:317 | -0.287 | 4.816e-06 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | tozasertib | GDSC1:32 | -0.143 | 3.696e-02 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | SNX-2112 | GDSC1:328 | -0.168 | 1.202e-02 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | QL-XI-92 | GDSC1:329 | 0.202 | 2.049e-03 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | XMD13-2 | GDSC1:330 | 0.159 | 1.837e-02 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | Torin 2 | GDSC1:371 | -0.157 | 2.013e-02 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | pilaralisib | GDSC1:372 | 0.166 | 1.368e-02 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | GDC0980 | GDSC1:382 | -0.17 | 1.087e-02 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | venetoclax | GDSC1:412 | -0.177 | 7.818e-03 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | NSC319726 | GDSC1:461 | -0.171 | 1.031e-02 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | ARRY-520 | GDSC1:474 | -0.183 | 5.683e-03 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | CGP-60474 | GDSC1:53 | -0.158 | 1.926e-02 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | BI-2536 | GDSC1:60 | -0.16 | 1.786e-02 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | KIN001-139 | GDSC1:86 | -0.149 | 2.866e-02 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | GW-843682X | GDSC1:87 | -0.167 | 1.256e-02 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | camptothecin | GDSC2:1003 | -0.248 | 1.046e-04 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | vinblastine | GDSC2:1004 | -0.21 | 1.306e-03 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | cytarabine | GDSC2:1006 | -0.153 | 2.457e-02 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | docetaxel | GDSC2:1007 | -0.146 | 3.208e-02 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | AZD7762 | GDSC2:1022 | -0.138 | 4.524e-02 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | afatinib | GDSC2:1032 | 0.181 | 6.251e-03 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | mirin | GDSC2:1048 | 0.152 | 2.537e-02 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | NVP-BEZ235 | GDSC2:1057 | -0.195 | 3.054e-03 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | 5-fluorouracil | GDSC2:1073 | 0.19 | 4.086e-03 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | sorafenib | GDSC2:1085 | 0.183 | 5.883e-03 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | BI-2536 | GDSC2:1086 | -0.155 | 2.249e-02 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | oxaliplatin | GDSC2:1089 | 0.149 | 2.927e-02 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | APR-246 | GDSC2:1131 | 0.2 | 2.328e-03 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | dinaciclib | GDSC2:1180 | -0.156 | 2.163e-02 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | bortezomib | GDSC2:1191 | -0.175 | 8.586e-03 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | BMS-345541 | GDSC2:1249 | 0.213 | 1.084e-03 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | epirubicin | GDSC2:1511 | -0.246 | 1.212e-04 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | AUY922 | GDSC2:1559 | -0.176 | 8.310e-03 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | I-BET-762 | GDSC2:1624 | 0.224 | 5.448e-04 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | oxaliplatin | GDSC2:1806 | 0.176 | 8.317e-03 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | teniposide | GDSC2:1809 | -0.185 | 5.165e-03 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | mitoxantrone | GDSC2:1810 | -0.167 | 1.288e-02 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | vincristine | GDSC2:1818 | -0.2 | 2.343e-03 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | Podophyllotoxin bromide | GDSC2:1825 | -0.233 | 2.916e-04 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | Elephantin | GDSC2:1835 | 0.148 | 2.989e-02 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | BI-97C1 | GDSC2:1849 | -0.222 | 5.901e-04 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | venetoclax | GDSC2:1909 | -0.139 | 4.340e-02 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | dactinomycin | GDSC2:1911 | -0.187 | 4.628e-03 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | cediranib | GDSC2:1922 | 0.146 | 3.308e-02 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | I-BRD9 | GDSC2:1928 | 0.187 | 4.720e-03 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | MIM-1 | GDSC2:1996 | 0.163 | 1.562e-02 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | Pyridostatin | GDSC2:2044 | 0.201 | 2.198e-03 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | vinorelbine | GDSC2:2048 | -0.175 | 8.553e-03 | ALL |
|
GINS4_Q9BRT9 | Canonical | GINS4 | ARRY-520 | GDSC1:474 | -0.379 | 4.653e-02 | LUNG |
